Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Respiratory syncytial virus immunobiology and pathogenesis.

× No keyword cloud information.

27 in total

1. Effects of alveolar macrophage depletion on liposomal vaccine protection against respiratory syncytial virus (RSV).

Authors: A Benoit; Y Huang; J Proctor; G Rowden; R Anderson
Journal: Clin Exp Immunol Date: 2006-07 Impact factor: 4.330

2. Circulating antibody-secreting cells during acute respiratory syncytial virus infection in adults.

Authors: F Eun-Hyung Lee; Ann R Falsey; Jessica L Halliley; Iñaki Sanz; Edward E Walsh
Journal: J Infect Dis Date: 2010-10-27 Impact factor: 5.226

3. Enhanced disease and pulmonary eosinophilia associated with formalin-inactivated respiratory syncytial virus vaccination are linked to G glycoprotein CX3C-CX3CR1 interaction and expression of substance P.

Authors: Lia M Haynes; Les P Jones; Albert Barskey; Larry J Anderson; Ralph A Tripp
Journal: J Virol Date: 2003-09 Impact factor: 5.103

Review 4. Viral infections in lung transplant recipients.

Authors: Pali Dedhiya Shah; John F McDyer
Journal: Semin Respir Crit Care Med Date: 2010-03-30 Impact factor: 3.119

5. A gammaherpesvirus licenses CD8 T cells to protect the host from pneumovirus-induced immunopathologies.

Authors: Bénédicte Machiels; Laurent Gillet; Mickaël Dourcy; Céline Maquet; Lorène Dams; Gautier Gilliaux; Justine Javaux; Daniel Desmecht; Matthias Mack; Benjamin G Dewals
Journal: Mucosal Immunol Date: 2020-05-18 Impact factor: 7.313

6. Modulation of protective immunity, eosinophilia, and cytokine responses by selective mutagenesis of a recombinant G protein vaccine against respiratory syncytial virus.

Authors: Yan Huang; Robert Anderson
Journal: J Virol Date: 2005-04 Impact factor: 5.103

7. Attenuation of live respiratory syncytial virus vaccines is associated with reductions in levels of nasal cytokines.

Authors: Ruth A Karron; Bhagvanji Thumar; Elizabeth Schappell; Ursula J Buchholz; Peter L Collins
Journal: J Infect Dis Date: 2013-03-12 Impact factor: 5.226

8. Protective memory responses are modulated by priming events prior to challenge.

Authors: John A Rutigliano; Melissa Y Morris; Wen Yue; Rachael Keating; Richard J Webby; Paul G Thomas; Peter C Doherty
Journal: J Virol Date: 2009-11-04 Impact factor: 5.103

9. Respiratory syncytial virus (RSV) G glycoprotein is not necessary for vaccine-enhanced disease induced by immunization with formalin-inactivated RSV.

Authors: Teresa R Johnson; Michael N Teng; Peter L Collins; Barney S Graham
Journal: J Virol Date: 2004-06 Impact factor: 5.103

10. Specific history of heterologous virus infections determines anti-viral immunity and immunopathology in the lung.

Authors: Hong D Chen; Armando E Fraire; Isabelle Joris; Raymond M Welsh; Liisa K Selin
Journal: Am J Pathol Date: 2003-10 Impact factor: 4.307